HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Viljami Jokinen Selected Research

Glial Cell Line-Derived Neurotrophic Factors (GDNF Family Ligands)

1/2020Novel RET agonist for the treatment of experimental neuropathies.
1/2017A Novel Small Molecule GDNF Receptor RET Agonist, BT13, Promotes Neurite Growth from Sensory Neurons in Vitro and Attenuates Experimental Neuropathy in the Rat.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Viljami Jokinen Research Topics

Disease

3Neuralgia (Stump Neuralgia)
01/2020 - 01/2017
2Hyperalgesia
05/2020 - 01/2018
1Pain (Aches)
05/2020
1Hypersensitivity (Allergy)
01/2017

Drug/Important Bio-Agent (IBA)

2Morphine (MS Contin)FDA LinkGeneric
05/2020 - 01/2018
2Opioid Analgesics (Opioids)IBA
05/2020 - 01/2018
2Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
01/2020 - 01/2017
2Glial Cell Line-Derived Neurotrophic Factors (GDNF Family Ligands)IBA
01/2020 - 01/2017
1Analgesics (Analgesic Drugs)IBA
05/2020
1morphine-3-glucuronideIBA
05/2020
1Substance PIBA
05/2020
1Neurotransmitter Agents (Neurotransmitter)IBA
05/2020
1Proto-Oncogene Proteins c-retIBA
01/2020
1RNA (Ribonucleic Acid)IBA
01/2018

Therapy/Procedure

1Ligation
01/2017